Norges Bank bought a new stake in shares of Oscar Health, Inc. (NYSE:OSCR - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 80,738 shares of the company's stock, valued at approximately $1,085,000.
Several other large investors also recently modified their holdings of OSCR. State Street Corp increased its position in Oscar Health by 6.0% in the third quarter. State Street Corp now owns 5,132,802 shares of the company's stock worth $108,867,000 after buying an additional 291,335 shares during the last quarter. Lingotto Investment Management LLP purchased a new stake in Oscar Health during the fourth quarter valued at about $2,543,000. GDS Wealth Management boosted its position in Oscar Health by 1,545.3% during the fourth quarter. GDS Wealth Management now owns 345,817 shares of the company's stock worth $4,648,000 after purchasing an additional 324,798 shares during the period. Victory Capital Management Inc. increased its stake in shares of Oscar Health by 296.0% in the fourth quarter. Victory Capital Management Inc. now owns 231,059 shares of the company's stock worth $3,105,000 after purchasing an additional 172,706 shares in the last quarter. Finally, Connor Clark & Lunn Investment Management Ltd. bought a new stake in shares of Oscar Health in the fourth quarter valued at approximately $5,672,000. Hedge funds and other institutional investors own 75.70% of the company's stock.
Analyst Ratings Changes
Separately, Wells Fargo & Company downgraded Oscar Health from an "overweight" rating to an "equal weight" rating and dropped their target price for the stock from $20.00 to $16.00 in a research report on Thursday, March 13th. Two research analysts have rated the stock with a sell rating, three have assigned a hold rating, two have given a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat.com, the stock has an average rating of "Hold" and a consensus price target of $20.21.
View Our Latest Stock Analysis on Oscar Health
Oscar Health Price Performance
Oscar Health stock traded up $0.05 during mid-day trading on Tuesday, hitting $12.47. 2,432,006 shares of the company traded hands, compared to its average volume of 3,865,218. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.73 and a current ratio of 0.73. Oscar Health, Inc. has a one year low of $11.47 and a one year high of $23.79. The stock has a market cap of $3.12 billion, a price-to-earnings ratio of -622.94 and a beta of 1.75. The stock has a fifty day moving average price of $13.95 and a 200-day moving average price of $15.26.
Oscar Health (NYSE:OSCR - Get Free Report) last announced its earnings results on Tuesday, February 4th. The company reported ($0.62) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.55) by ($0.07). Oscar Health had a return on equity of 2.28% and a net margin of 0.28%. On average, equities analysts predict that Oscar Health, Inc. will post 0.69 earnings per share for the current fiscal year.
About Oscar Health
(
Free Report)
Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.
Featured Stories

Before you consider Oscar Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oscar Health wasn't on the list.
While Oscar Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.